Covid 19

MONOCLONOAL ANTIBODY TREATMENT

BY APPOINTMENT ONLY

Learn More

Rgen-Cov-Logo-2.png

TruCare Pharmacy is providing REGEN-COV Monoclonal Antibody Therapy for both treatment and prophylaxis post-exposure.

Disclaimer: There is a potential risk of treatment failure due to the development of viral variants that are resistant to REGEN-COV.

What are Monoclonal Antibodies?

 

Monocalonal Antibodies (mAb) are laboratory-made proteins that mimic the immune system’s ability to fight off harmful viruses. They are used to treat an existing SARS-CoV-2 infection and may help prevent progression of the disease that would otherwise require hospitalization.

 

mAb treatment for COVID-19 is an investigational medicine and not a substitute for getting vaccinated. The vaccine trains the body to recognize the virus to be able to fight a future infection, while mAb is used to combat a current infection. To note, protection from a COVID-19 vaccine lasts longer than treatment from mAb therapy. Where possible, it is preferable to get vaccinated rather than to contract COVID-19 and need mAb therapy.

 

The monoclonal antibody treatment that we provide is called REGEN-COV, which is made up of the drugs casirivimab and imdevimab. They are administered together via four subcutaneous injections. Please refer to the FDA's EUA for patients:

 Who is Eligible for Monoclonal Antibody Treatment?

 

To be eligible, individuals must meet all of the following criteria:

  • be 12 years or older;

  • weigh at least 88 lbs;

  • be at high risk for progressing to severe COVID-19 (see high risk list below);

  • have tested positive for COVID-19 or been exposed to a positive case;

  • be within 10 days of symptom onset (ideally as soon as possible after diagnosis, even if symptoms are not too bad); AND

  • not be receiving oxygen therapy.

 

High risk includes any of the following:

  • 65 years or older;

  • Chronic kidney disease;

  • Heart or lung disease;

  • BMI of 25 or greater;

  • Pregnancy;

  • Diabetes;

  • Sickle cell disease;

  • Neurodevelopmental disorders (for example, cerebral palsy);

  • Having a medical-related technological dependence (for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID 19); OR

  • Other medical conditions or factors (for example, race or ethnicity) that may also place individual patients at high risk for progression to severe COVID-19.

 

REGEN-COV is not approved for use in patients who are hospitalized due to COVID-19 or who require oxygen therapy. Benefits of treatment have not been observed in patients hospitalized due to COVID-19. Monoclonal antibodies may be associated with worse clinical outcomes when given to patients with COVID-19 requiring oxygen ventilation.

 

If you have questions about whether mAb treatment is right for you, contact your physician or give us a call at 346-980-5828

 

We offer mAb treatments by appointment only.   Please book  below or call us at 346-980-5828